How big is the Blood Plasma Derivatives Market | Demand & Growth Outlook 2025

Q: How big is the blood plasma derivatives market?

The blood plasma derivatives market was USD 38 billion in 2024 and is projected to reach USD 65 billion by 2031.

Q: What is driving growth in the blood plasma derivatives market?

Increased demand for immunoglobulins and plasma-derived therapies for chronic diseases are driving growth of the market.

Q: What are the major trends in this blood plasma derivatives market?

Automation in fractionation, expansion of plasma biobanks, and rising use of albumin are major trends.

Q: What challenges does the blood plasma derivatives market face?

High cost of plasma therapies, limited donor availability, and complex regulatory compliance are the challenges faced by the market.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA5163

Publication Date: Jul 2025

What is the size of the Blood Plasma Derivatives Market?

According to 6Wresearch internal database and industry insights, the Global Blood Plasma Derivatives Market was exhibited at USD 38 billion in 2024 and is projected to reach USD 65 billion by 2031, growing at a CAGR of 8.2% during the forecast period 2025–2031.

Due to several factors including the rising prevalence of immunodeficiency disorders, increased surgical procedures, and greater demand for plasma-derived therapies across the globe, the market is expected for the robust growth in the coming years.

Key Growth Factors of the Blood Plasma Derivatives Market

Increasing cases of haemophilia, immune disorders, and liver diseases
Growth in use of plasma derivatives in emergency and trauma care
Expansion of blood plasma collection and fractionation infrastructure
Government funding and public-private partnerships in biopharmaceuticals
Advancements in cold chain logistics and plasma processing technologies

Blood Plasma Derivatives Market Trends

Blood plasma derivatives market is moving forward with the notable trends including the rising demand for immunoglobulins, albumin, and coagulation factors driven by chronic and genetic diseases. The industry is seeing strategic alliances and contract manufacturing for large-scale plasma derivative production. Further, there is an increase in investments in plasma biobanks and automation in plasma fractionation processes. Global supply chain networks are being strengthened to meet rising demand in Asia-Pacific and Latin America.

Emerging Developments in the Blood Plasma Derivatives Market

Blood plasma derivatives market is developing with the emphasizing focus on recombinant plasma alternatives and synthetic biologics to reduce donor dependency. Now, the companies are using AI is being used to optimize plasma collection and distribution logistics. Gene therapy research is aligning with plasma-based treatments for rare diseases. Further, next-gen purification technologies are improving yield and safety of plasma derivatives.